FDA grants industry requests for interchangeability guidance comment extension
The US FDA has extended the comment period for its draft biosimilar interchangeability guidance until May 19.
Archives for March 15, 2017
GE Healthcare installs purification tech at FujiFilm Diosynth site
GE Healthcare has completed another tech installation at FujiFilm Diosynth’s biopharmaceuticals facility in Billingham, UK, integrating a single-use purification system with bioreactors it provided in 2014.
Reader's poll
American-made biosimilars a differentiator in US market, Coherus
US patients and physicians favour domestically-made biosimilars according to Coherus Biosciences. But if quality is assured should the manufacturing location matter?